申请人:ZENG Qingping
公开号:US20090275592A1
公开(公告)日:2009-11-05
The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.
The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
本发明涉及一种公式I的杂环化合物及其组合物,其中变量具有本文所提供的定义,其在治疗由蛋白激酶B(PKB)介导的疾病方面具有用途。本发明还涉及这种化合物和组合物在治疗与异常细胞生长、癌症、炎症和代谢紊乱相关的疾病状态方面的治疗用途。